Eli Lilly and Co at Citi BioPharma Conference (Virtual) Transcript
Hi. My name is Michael Guba. I'm Citi's U.S. Healthcare Sector Specialist, filling in for Andrew Baum, who's our Global Head of Healthcare Research on -- covers major pharmaceuticals here for Citi. I'm lucky enough to be joined by Anat Ashkenazi, Senior Vice President and CFO of Eli Lilly, for a quick little fireside chat here.
Taking verbose tact here, I'm here to moderate, not monopolize. So please feel free to send any of your questions to [email protected]. I'll start off with a couple of openers. But obviously, the whole point of the conference is to have a solid investor participation, so I'd appreciate anything you guys have to ask.
Anat, thank you for joining us today.
Great. Great to be here.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
